{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:43:22Z","timestamp":1767851002817,"version":"3.49.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n                           <jats:sup>18<\/jats:sup>F-THK5351 was initially developed to target tau aggregates in neurofibrillary tangles. However, it was also shown to bind to an enzyme, monoamine oxidase B, which is highly expressed in the outer mitochondrial membrane of astrocytes. In a case with glioblastoma, both <jats:sc>l<\/jats:sc>-[methyl-<jats:sup>11<\/jats:sup>C]-methionine PET and <jats:sup>18<\/jats:sup>F-THK5351 PET showed increased uptake in the tumor. On the other hand, in another case with primary central nervous system lymphoma, <jats:sc>l<\/jats:sc>-[methyl-<jats:sup>11<\/jats:sup>C]-methionine PET showed increased uptake in the tumor, but <jats:sup>18<\/jats:sup>F-THK5351 PET showed no abnormal uptake in the tumor. <jats:sup>18<\/jats:sup>F-THK5351 PET might be helpful in differentiating between glioblastoma and primary central nervous system lymphoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003699","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T15:07:33Z","timestamp":1621868853000},"page":"772-773","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Increased Uptake of 18F-THK5351 in Glioblastoma But Not in Primary Central Nervous System Lymphoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Katsuya","family":"Mitamura","sequence":"first","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Norikane","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Miyake","sequence":"additional","affiliation":[{"name":"Neurological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.115.166652","article-title":"Structure\u2013activity relationship of 2-arylquinolines as PET imaging tracers for tau pathology in Alzheimer disease","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain","volume":"9","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000001868","article-title":"Potential use of 18F-THK5351 PET to identify Wallerian degeneration of the pyramidal tract caused by cerebral infarction","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2967\/jnumed.117.197426","article-title":"Correlations of 18F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0306-4522(96)83013-2","article-title":"Molecular neuroanatomy of human monoamine oxidases a and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry","volume":"70","year":"1996","journal-title":"Neuroscience"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0306-4522(94)90311-5","article-title":"Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography","volume":"62","year":"1994","journal-title":"Neuroscience"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/RLU.0000000000002564","article-title":"Monoamine oxidase B binding of 18F-THK5351 to visualize glioblastoma and associated gliosis: an autopsy-confirmed case","volume":"44","year":"2019","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:04:00Z","timestamp":1750536240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003699","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,20]]}}}